Crossref
Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?
Cosmoderma · 18.07.2026 · 6 · 86
DOI: 10.25259/csdm_94_2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cosmoderma, online erschienen am 18.07.2026. Verfasst von Rachita S Dhurat und 3 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dhurat, R. S., Sharma, R., Ranka, A., & Kale, G. (2026). Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?. Cosmoderma, 6, 86. https://doi.org/10.25259/csdm_94_2026
Vancouver
Dhurat RS, Sharma R, Ranka A, Kale G. Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?. Cosmoderma. 2026;6:86. doi:10.25259/csdm_94_2026
BibTeX
@article{Dhurat2026,
author = {Dhurat, Rachita S and Sharma, Richa and Ranka, Archi and Kale, Grishma},
title = {Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?},
journal = {Cosmoderma},
year = {2026},
volume = {6},
pages = {86},
doi = {10.25259/csdm_94_2026}
}
EUVIMED